Tag: IDE trial
SynerFuse announces presentation of IDE proof-of-concept study data
SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented data from the study’s...
Simplify Medical completes enrolment in US IDE pivotal trial of Simplify...
Simplify Medical, maker of the Simplify cervical artificial disc, has announced that it has completed the enrolment and treatment of all patients in its US...
Cerapedics announces first patients enrolled in IDE clinical trial of P-15L...
The first patients have been enrolled in an investigational device exemption (IDE) clinical trial evaluating the safety and efficacy of the next-generation P-15L peptide...
Mainstay Medical announces the completion of all implants in the ReActiv8-B...
Mainstay Medical International, a medical device company focused on bringing to market ReActiv8, an implantable neurostimulation system to treat chronic low back pain, announces...
Spineology completes enrollment in IDE trial for mesh fusion implant
Spineology has announced that enrollment is now complete in the company's Spineology Clinical Outcomes Trial (SCOUT) clinical trial.
The SCOUT IDE, conducted under an FDA-approved...